Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
About this item
Full title
Author / Creator
Nakamura, Kohei , Aimono, Eriko , Oba, Junna , Hayashi, Hideyuki , Tanishima, Shigeki , Hayashida, Tetsu , Chiyoda, Tatsuyuki , Kosaka, Takeo , Hishida, Tomoyuki , Kawakubo, Hirohumi , Kitago, Minoru , Okabayashi, Koji , Funakoshi, Takeru , Okita, Hajime , Ikeda, Sadakatsu , Takaishi, Hiromasa and Nishihara, Hiroshi
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Assessing Erb-b2 receptor tyrosine kinase 2 (
ERBB2
) amplification status in breast and gastric cancer is necessary for deciding the best therapeutic strategy. Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are currently used for assessing protein levels and gene copy number (CN), respectively. The use of next-gener...
Alternative Titles
Full title
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7954749
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7954749
Other Identifiers
ISSN
1357-0560
E-ISSN
1559-131X
DOI
10.1007/s12032-021-01482-1
